Agios Pharmaceuticals Inc (NASDAQ: AGIO) May Be Attracting Institutional Investments

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

Agios Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Agios Pharmaceuticals Inc is $2.05B. A total of 1.03 million shares were traded on the day, compared to an average of 821.73K shares.

In the most recent transaction, Milanova Tsveta sold 2,804 shares of AGIO for 32.18 per share on Jan 06 ’25. After the transaction, the Chief Commercial Officer now owns 18,906 company shares. In a previous transaction on Jan 03 ’25, Milanova Tsveta bought 2,804 shares at 31.84 per share.

Among the insiders who sold shares, Scadden David disposed of 200 shares on Dec 11 ’24 at a per-share price of $46.28. This resulted in the Director holding 15,483 shares of AGIO after the transaction. In another insider transaction, Washburn Theodore James Jr. sold 772 shares at $56.09 per share on Nov 08 ’24. Company shares held by the Principal Accounting Officer now total 813.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, AGIO has a high of $62.58 and a low of $20.96.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. AGIO’s latest balance sheet shows that the firm has $1.02B in Cash & Short Term Investments as of fiscal 2021. There were $97.09M in debt and $59.83M in liabilities at the time. Its Book Value Per Share was $28.53, while its Total Shareholder’s Equity was $1.29B.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AGIO is Buy with a score of 4.22.

Most Popular

Related Posts